AIM2 and ovarian carcinoma: The authors found that high expression levels of AIM2 mRNA were significantly correlated with poor progression-free survival (PFS), and that increased protein levels of AIM2 were associated with Ki67-positive staining in human tissues collected from ovarian cancer patients, supporting its role in cancer progression [67].